Litcius/Paper detail

Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial

ZhiCheng Lai, Minke He, Xiaoyun Bu, Yu-Jie Xu, YeXing Huang, Dongsheng Wen, QiJiong Li, Li Xu, YaoJun Zhang, Wei Wei, MinShan Chen, Anna Kan, Ming Shi

2022European Journal of Cancer150 citationsDOI

Topics & Concepts

MedicineLenvatinibFOLFOXInternal medicineOxaliplatinClinical endpointHepatocellular carcinomaAdverse effectOncologyGastroenterologySurgeryCancerSorafenibClinical trialColorectal cancerHepatocellular Carcinoma Treatment and PrognosisCancer Mechanisms and TherapyLiver physiology and pathology
Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial | Litcius